Gemcitabine

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23052 publications

First-Line Chemotherapy Regimens for Unresectable Locally Advanced or Metastatic Biliary Tract Cancer: A Systematic Review and Bayesian Network Meta-Analysis.

First-Line Chemotherapy Regimens for Unresectable Locally Advanced or Metastatic Biliary Tract Cancer: A Systematic Review and Bayesian Network Meta-Analysis.

Journal: JAMA network open

Published: April 15, 2026

Inhibition of Gemcitabine-Induced Autophagy in Cancer-Associated Fibroblasts Reduces Collagen I and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer.

Inhibition of Gemcitabine-Induced Autophagy in Cancer-Associated Fibroblasts Reduces Collagen I and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer.

Journal: Stem cells and development

Published: April 15, 2026

Photocaging the C6-carboxylate of β-glucuronide prodrugs enables spatiotemporally controlled release of anticancer agents via a dual activation strategy.

Photocaging the C6-carboxylate of β-glucuronide prodrugs enables spatiotemporally controlled release of anticancer agents via a dual activation strategy.

Journal: Organic & biomolecular chemistry

Published: April 13, 2026

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Journal: JCO global oncology

Published: April 10, 2026

A virtual cohort framework with applications to adoptive cell therapy in bladder cancer.

A virtual cohort framework with applications to adoptive cell therapy in bladder cancer.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors.

PRMT5 is Frequently Upregulated and a Potential Therapeutic Target in MTAP-deficient Malignant Peripheral Nerve Sheath Tumors.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

In brief: Optune Pax - a portable device for pancreatic cancer.

In brief: Optune Pax - a portable device for pancreatic cancer.

Journal: The Medical letter on drugs and therapeutics

Published: April 10, 2026

Response to comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'.

Response to comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'.

Journal: BJU international

Published: April 08, 2026

In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery.

In Vivo-Assembled Artificial Base-Albumin Platform for Tumor-Targeted General Drug Delivery.

Journal: ACS nano

Published: April 07, 2026

Comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'.

Comment on 'Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer'.

Journal: BJU international

Published: April 07, 2026

MerTK inhibition by UNC569 triggers DNA damage and JNK/p38 MAPK cascade-driven apoptosis in pancreatic cancer.

MerTK inhibition by UNC569 triggers DNA damage and JNK/p38 MAPK cascade-driven apoptosis in pancreatic cancer.

Journal: Acta biochimica et biophysica Sinica

Published: April 06, 2026

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.

Journal: Scientific reports

Published: April 03, 2026

Showing 1-12 of 23,052

Last Updated: 04/28/2026